Updated:
Grace Therapeutics, Inc.
Grace Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001444192, and its reported...
Overview
Grace Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001444192, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-06-18, it reported net income of USD -7,793,000; total assets of USD 66,654,000 for the fiscal period ended 2026-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Grace Therapeutics, Inc.
- Former names in filing history
- Acasti Pharma Inc. (2008-09-02 to 2024-10-25)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Princeton, NJ, United States
- Incorporated in
- DE
- Fiscal year end
- March 31
- Ticker
- Nasdaq: GRCE
- SEC CIK
- 0001444192
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2026USD | -$7.8M | $66.7M | $17.0M | -$8.9M | |
| FY2025USD | -$9.6M | $72.0M | $22.1M | -$14.9M | |
| FY2024USD | -$12.9M | $73.3M | $23.0M | -$12.3M | |
| FY2023USD | -$42.4M | $79.1M | $27.9M | -$15.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Grace Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.